LRAT Antibodies

Santa Cruz Biotechnology provides a broad selection of LRAT monoclonal antibodies for applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). LRAT (lecithin-retinol acyltransferase) functions as a key enzyme in retinoid metabolism, playing a crucial role in vision and cellular differentiation. LRAT catalyzes the conversion of all-trans-retinol to retinyl esters, which is essential for vitamin A storage and transport throughout the body. Research focusing on LRAT has revealed its significance in maintaining proper retinal function and overall metabolic health. Scientists studying LRAT can gain valuable insights into various physiological processes and potential therapeutic approaches for retinal diseases. Understanding LRAT's molecular mechanisms and regulatory pathways continues to be an active area of investigation in vision research and metabolic studies. Investigating LRAT expression patterns helps researchers better comprehend vitamin A metabolism and its impact on cellular processes. LRAT monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to advance our understanding of retinoid metabolism and its implications for human health.